pubmed-article:14603996 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
pubmed-article:14603996 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
pubmed-article:14603996 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:14603996 | pubmed:dateCreated | 2003-11-7 | lld:pubmed |
pubmed-article:14603996 | pubmed:abstractText | An inhibitor of interferon antiviral activity, which is absent in healthy HIV-seronegative persons, was detected in the sera of all 29 HIV-seropositive study participants. The relationship of the level of interferon inhibitor to CD4 count and HIV-RNA copy number was statistically significant in distinct models. Levels of interferon inhibitor declined by an average of 41-60% in patients who underwent a change in anti-retroviral therapy. Interferon inhibitor levels appear to decline as CD4 cell count rises and HIV-RNA levels fall. This suggests that interferon inhibitor may have a significant role in the host immune response to HIV infection. | lld:pubmed |
pubmed-article:14603996 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:language | eng | lld:pubmed |
pubmed-article:14603996 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14603996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14603996 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14603996 | pubmed:month | Nov | lld:pubmed |
pubmed-article:14603996 | pubmed:issn | 0882-0139 | lld:pubmed |
pubmed-article:14603996 | pubmed:author | pubmed-author:SchwartzStanl... | lld:pubmed |
pubmed-article:14603996 | pubmed:author | pubmed-author:HewittRoss... | lld:pubmed |
pubmed-article:14603996 | pubmed:author | pubmed-author:NairMadhavan... | lld:pubmed |
pubmed-article:14603996 | pubmed:author | pubmed-author:ChadhaKailash... | lld:pubmed |
pubmed-article:14603996 | pubmed:author | pubmed-author:DemeterLisa... | lld:pubmed |
pubmed-article:14603996 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14603996 | pubmed:volume | 32 | lld:pubmed |
pubmed-article:14603996 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14603996 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14603996 | pubmed:pagination | 299-312 | lld:pubmed |
pubmed-article:14603996 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:meshHeading | pubmed-meshheading:14603996... | lld:pubmed |
pubmed-article:14603996 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14603996 | pubmed:articleTitle | Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy. | lld:pubmed |
pubmed-article:14603996 | pubmed:affiliation | Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. kailash.chadha@roswellpark.org | lld:pubmed |
pubmed-article:14603996 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14603996 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:14603996 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |